Healthy Males and Females of Non-Childbearing Potential Volunteers Needed
Study Reference: 8480-232 G5
Labcorp - Dallas
Compensation
Up to
$4881
Closed
Study Details
This is a research study for an investigational drug being developed for the treatment of certain types of cancer. The purpose of this study is to look at how much of the study drug enters the circulation of the body when given as a tablet compared to a capsule formulation. The study will measure how much of the study drug gets into the blood and how long the body takes to get rid of it. The study will also evaluate the side effects of the study drug.
Study Period
Study involves 1 stay of 12 nights, plus 1 follow-up call
Group 5:
Check-in: April 10
Check-out: April 22
Follow up Call: April 28
Compensation
up to $4,881
Eligibility Criteria
- Age: 18 – 65
- Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65
- Body Mass Index between 18-32
Research Location:
Labcorp - Dallas
Share with a Friend
Company Information
Labcorp
Clear and confident health care decisions begin with questions. Labcorp is constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, Labcorp accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, Labcorp is here for you. Together, Labcorp working to put people first.
Contact Information
+18664293700
1341 W. Mockingbird Lane, Suite 200E
Dallas, TX 75247
United States
Share with a Friend
Other Trials for You
Closed
Featured
Start Date: April 13, 2023 (check-in)
The primary purpose of Part A is to determine the safety and tolerability (side effects) of single doses of the study drug at increasing dose levels. You will be given a single, oral dose of the study drug or a placebo (inactive drug).
Compensation Up to
: $2346
BMI: 18-
32
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Closed
Start Date: April 13, 2023 (check-in)
Compensation:
Up to
$2346
Labcorp - Daytona Beach
The primary purpose of Part A is to determine the safety and tolerability (side effects) of single doses of the study drug at increasing dose levels. You will be given a single, oral dose of the study drug or a placebo (inactive drug).
BMI: 18-
32
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Not yet recruiting
Featured
CenExel ACT is looking for male and female volunteers for psoriasis study.
Compensation Up to
: $
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
CenExel ACT - Anaheim
CenExel ACT is looking for male and female volunteers for psoriasis study.
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
Recruiting
Featured
Start Date: April 24, 2023 (check-in)
Altasciences in Overland Park is looking for healthy elderly volunteers for a clinical research study.
Compensation Minimum
: $8250
BMI: 65-
85
Volunteer: Healthy
Gender: Man, Woman
Age: 65-
85
Smokers Allowed: No
Recruiting
Start Date: April 24, 2023 (check-in)
Compensation:
Minimum
$8250
Altasciences - Overland Park
Altasciences in Overland Park is looking for healthy elderly volunteers for a clinical research study.
BMI: 65-
85